Abstract
The authors found that growth hormone (GH) response to edrophonium was no different in 12 Alzheimer's disease patients than in eight healthy elderly subjects. Previously reported differences could be due to differences in gender or baseline GH concentrations between patients and control subjects.
| Original language | English |
|---|---|
| Pages (from-to) | 1007-1009 |
| Number of pages | 3 |
| Journal | American Journal of Psychiatry |
| Volume | 145 |
| Issue number | 8 |
| DOIs | |
| Publication status | Published - 1988 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Growth hormone response to edrophonium in patients with Alzheimer's disease and normal control subjects'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver